Federated Hermes’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.5K	Buy	4,739 +734	+18%	+$5.85K	﹤0.01%	1696
2025 Q4	$24.1K	Sell	4,005 -4,080	-50%	-$24.3K	﹤0.01%	1733
2025 Q3	$46.2K	Buy	8,085 +4,899	+154%	+$25.1K	﹤0.01%	1684
2025 Q2	$16.1K	Sell	3,186 -15	-0.5%	-$80	﹤0.01%	1744
2025 Q1	$20.7K	Sell	3,201 -3,420	-52%	-$30.4K	﹤0.01%	1719
2024 Q4	$48.6K	Sell	6,621 -44,630	-87%	-$352K	﹤0.01%	1674
2024 Q3	$384K	Sell	51,251 -248,897	-83%	-$2.16M	﹤0.01%	1377
2024 Q2	$2.67M	Buy	300,148 +298,603	+19,327%	+$2.86M	0.01%	857
2024 Q1	$15.7K	Sell	1,545 -5,313	-77%	-$54.1K	﹤0.01%	1746
2023 Q4	$69K	Buy	+6,858	New	+$62.7K	﹤0.01%	1614
2023 Q3	–	Sell	-1,140	Closed	-$28K	–	2209
2023 Q2	$28K	Sell	1,140 -946	-45%	-$23.8K	﹤0.01%	1749
2023 Q1	$48.5K	Buy	2,086 +286	+16%	+$7.32K	﹤0.01%	1738
2022 Q4	$45.6K	Sell	1,800 -236,113	-99%	-$5.79M	﹤0.01%	1726
2022 Q3	$4.59M	Buy	+237,913	New	+$6.05M	0.01%	692
2022 Q2	–	Sell	-74	Closed	-$2K	–	2288
2022 Q1	$2K	Buy	+74	New	+$2.19K	﹤0.01%	2039
2020 Q2	–	Sell	-26,058	Closed	-$893K	–	2384
2020 Q1	$893K	Buy	+26,058	New	+$700K	﹤0.01%	1182